Abivax ABVX
NASDAQ ABVX
$96.85 +5.79 (+6.36%)
At close: Sep 28, 2026 · 4:00 PM EDT

Abivax (ABVX) EPS (Diluted) (2022 - 2026)

Updated

Abivax (ABVX) reported EPS (Diluted) of -$1.96 for Q2 2026, compared with -$0.87 a year earlier.

Analysis

Abivax (ABVX) EPS (Diluted) (2022 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Abivax's EPS (Diluted) came in at -$6.73; for FY2025, it came in at -$5.46.

  • By year, EPS (Diluted) came in at -$3.03 in FY2024, -$3.71 in FY2023, -$3.35 in FY2022 and -$3.25 in FY2021.
  • Five-year quarterly EPS (Diluted) spans a low of -$2.84 in Q3 2025 and a high of $0.00 in Q4 2024.
  • Per Business Quant data, the three quarters before Q2 2026 came in at -$0.82 (Q1 2026), -$1.37 (Q4 2025) and -$2.84 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 2.27
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 2.04
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn -0.54
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 1.67
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn 1.85
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 4.37
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn -8.44
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn -0.04
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 4.31
10 Abivax 7.15 Bn 7.15 Bn - -1.96
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.96
Mar 31, 2026 -0.82
Dec 31, 2025 -1.37
Sep 30, 2025 -2.84
Jun 30, 2025 -0.87
Mar 31, 2025 -0.87
Dec 31, 2024 0.00
Sep 30, 2024 -1.41
Jun 30, 2024 -0.97
Mar 31, 2024 -1.08
Dec 31, 2023 0.00
Dec 31, 2022 0.00
API Access

Abivax EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=ABVX&period=max&api_key=YOUR_API_KEY